Artificial Intelligence in Drug Discovery: A Conversation with Dekel Gelbman, CEO of FDNA
“When you talk about precision medicine every disease can become somewhat of a rare disease because you’re going to Read more
FDNA’s Keynote at ePharma: Using Next-Generation Phenotyping For Precision Medicine Across the Pharma Value Chain
NOTE: This post is based on a presentation made at the March 2018 ePharma conference in New York City. Read more
Drug Delivery Partnership: Precision Medicine Drives Discovery, Development and Commercialization in Pharma
In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only Read more